BCL2 Inhibition Reveals a Dendritic Cell-Specific Immune Checkpoint That Controls Tumor Immunosurveillance.
Zhao L, Liu P, Mao M, Zhang S, Bigenwald C, Dutertre CA, Lehmann CHK, Pan H, Paulhan N, Amon L, Buqué A, Yamazaki T, Galluzzi L, Kloeckner B, Silvin A, Pan Y, Chen H, Tian AL, Ly P, Dudziak D, Zitvogel L, Kepp O, Kroemer G.
Zhao L, et al. Among authors: pan h, pan y.
Cancer Discov. 2023 Nov 1;13(11):2448-2469. doi: 10.1158/2159-8290.CD-22-1338.
Cancer Discov. 2023.
PMID: 37623817
Free PMC article.